Pyrazolo Minocycline, identified by its CAS number 182004-72-4, is a synthetic derivative of minocycline, which is a tetracycline antibiotic. This compound exhibits a unique pyrazole ring structure that enhances its pharmacological properties. Pyrazolo Minocycline is characterized by its broad-spectrum antibacterial activity, particularly against Gram-positive and Gram-negative bacteria, making it effective in treating various infections. Additionally, it possesses anti-inflammatory properties, which can be beneficial in managing conditions like acne and other inflammatory skin disorders. The compound's mechanism of action involves inhibiting bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the growth and reproduction of bacteria. Furthermore, it has been studied for its potential neuroprotective effects and its role in modulating immune responses. As with other tetracyclines, it is important to consider its pharmacokinetics, potential side effects, and contraindications when used in clinical settings. Overall, Pyrazolo Minocycline represents a promising advancement in antibiotic therapy with additional therapeutic applications.

Pyrazolo Minocycline

182004-72-4: Pyrazolo Minocycline, identified by its CAS number 182004-72-4, is a synthetic derivative of minocycline, which is a tetracycline antibiotic. This compound exhibits a unique pyrazole ring structure that enhances its pharmacological properties. Pyrazolo Minocycline is characterized by its broad-spectrum antibacterial activity, particularly against Gram-positive and Gram-negative bacteria, making it effective in treating various infections. Additionally, it possesses anti-inflammatory properties, which can be beneficial in managing conditions like acne and other inflammatory skin disorders. The compound's mechanism of action involves inhibiting bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the growth and reproduction of bacteria. Furthermore, it has been studied for its potential neuroprotective effects and its role in modulating immune responses. As with other tetracyclines, it is important to consider its pharmacokinetics, potential side effects, and contraindications when used in clinical settings. Overall, Pyrazolo Minocycline represents a promising advancement in antibiotic therapy with additional therapeutic applications.

CAS 182004-72-4

Pyrazolo Minocycline

Benzo[g]naphth[1,2,3-cd]indazole-4-carboxamide, 6,9-bis(dimethylamino)-2,2b,3,6,6a,7,7a,8-octahydro-2b,5,12-trihydroxy-3-oxo-, (2bS,6S,6aS,7aR)-

Ref: IN-DA00239G

Pyrazolo Minocycline

Ref: ST-EA-CP-M54021